Operating
Benefit from Receivables
Cencora Benefit from Receivables decreased by 37676.9% to -$4.89M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 157.6%, from $8.48M to -$4.89M. Over 3 years (FY 2022 to FY 2025), Benefit from Receivables shows an upward trend with a 34.4% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
First reportedQ1 2014
Last reportedQ2 2026May 6, 2026
Metric ID:
csco_benefit_from_receivablesHistorical Data
19 periods
| Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.68M | $2.19M | $5.22M | $12.72M | $5.93M | -$1.49M | $10.95M | $11.80M | $33.13M | $15.80M | $11.80M | $2.62M | $10.62M | $3.87M | $8.48M | $33.16M | $17.79M | $13.00K | -$4.89M |
| QoQ Change | — | -67.2% | +138.0% | +143.9% | -53.4% | -125.1% | +836.7% | +7.8% | +180.7% | -52.3% | -25.3% | -77.8% | +305.4% | -63.5% | +119.2% | +290.8% | -46.3% | -99.9% | <-999% |
| YoY Change | — | — | — | +90.5% | — | -167.8% | +109.9% | -7.2% | +458.6% | >999% | +7.8% | -77.8% | -67.9% | -75.5% | -28.1% | >999% | +67.6% | -99.7% | -157.6% |
Range-$4.89M – $33.16M
CAGR-6.7%
Avg YoY Growth+158.8%
Median YoY Growth-7.2%
Current Streak3 quarters decline
Benefit from Receivables at Other Companies
Frequently Asked Questions
- What is Cencora's benefit from receivables?
- Cencora (COR) reported benefit from receivables of -$4.89M in Q1 2026.
- How has Cencora's benefit from receivables changed year-over-year?
- Cencora's benefit from receivables decreased by 157.6% year-over-year, from $8.48M to -$4.89M.
- What is the long-term trend for Cencora's benefit from receivables?
- Over 3 years (2022 to 2025), Cencora's benefit from receivables has grown at a 34.4% compound annual growth rate (CAGR), from $26.05M to $63.31M.